Search

everythinglearnresearchcommunity

for

Search:↓

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Certain gene variations increase the risk of alopecia areata in Koreans.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Si Jun Zi Tang may slow aging by affecting specific cell signaling pathways.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

CD2 might be a new treatment target for patchy alopecia areata.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Researchers found four genes that could help diagnose severe alopecia areata early.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Erdr1 could be a new marker for diagnosing hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Pantethine may boost the immune system's ability to fight sarcoma.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Apremilast shows promise for several skin conditions but needs more research.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Fzd2 is important for skin and hair development through various signaling ways.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.